Samuel Fortin Selected Research

Monoglycerides

9/2017	Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer.
7/2017	Eicosapentaenoic acid monoglyceride resolves inflammation in an ex vivo model of human peripheral blood mononuclear cell.
7/2015	Effect of docosahexaenoic acid monoacylglyceride on systemic hypertension and cardiovascular dysfunction.
5/2015	Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model.
9/2013	Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel Fortin Research Topics

Disease

8	Inflammation (Inflammations) 05/2018 - 08/2011
5	Neoplasms (Cancer) 11/2017 - 09/2013
4	Hypersensitivity (Allergy) 07/2017 - 08/2011
3	Asthma (Bronchial Asthma) 07/2017 - 08/2011
2	Cystic Fibrosis (Mucoviscidosis) 05/2018 - 10/2015
2	Carcinoma (Carcinomatosis) 11/2017 - 09/2013
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 09/2013
2	Arthritis (Polyarthritis) 07/2017 - 05/2015
2	Vascular Remodeling 07/2015 - 08/2014
2	Pulmonary Hypertension 08/2014 - 10/2011
2	Pneumonia (Pneumonitis) 08/2014 - 08/2011
1	Adenocarcinoma 11/2017
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Infarction (Infarctions) 01/2016
1	Colitis 01/2016
1	Hypertension (High Blood Pressure) 07/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Rheumatoid Arthritis 05/2015
1	Right Ventricular Hypertrophy 08/2014
1	Adenocarcinoma of Lung 09/2013
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2012
1	Respiratory Hypersensitivity 08/2011

Drug/Important Bio-Agent (IBA)

9	docosahexaenoic acid monoacylglycerideIBA 05/2018 - 10/2011
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2018 - 09/2013
5	1-eicosapentaenoylglycerolIBA 09/2017 - 09/2013
5	MonoglyceridesIBA 09/2017 - 09/2013
5	Eicosapentaenoic AcidIBA 09/2017 - 09/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2018 - 07/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 07/2012
3	Docosahexaenoic AcidsIBA 01/2016 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 08/2011
2	EnzymesIBA 07/2017 - 08/2011
2	Interleukin-6 (Interleukin 6)IBA 07/2017 - 10/2015
2	docosapentaenoic acidIBA 05/2015 - 09/2013
2	1-O-docosapentaenoylglycerolIBA 08/2014 - 09/2013
2	Myosin-Light-Chain PhosphataseIBA 07/2012 - 08/2011
1	Carboplatin (JM8)FDA LinkGeneric 11/2017
1	OilsIBA 09/2017
1	CytokinesIBA 07/2017
1	Mitochondrial Permeability Transition PoreIBA 01/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	SolutionsIBA 10/2015
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 10/2015
1	phorbolIBA 10/2015
1	MucinsIBA 10/2015
1	CarbohydratesIBA 07/2015
1	LipidsIBA 07/2015
1	Vitamin E FDA LinkGeneric 05/2015
1	resolvin D1IBA 12/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2014
1	MonocrotalineIBA 08/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 09/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2013
1	Myosins (Myosin)IBA 07/2012
1	Protein Kinase CIBA 02/2012
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 02/2012
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 08/2011
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 08/2011
1	CRBM 0244IBA 08/2011

Therapy/Procedure

2	Oral Administration 09/2013 - 09/2013